Analyst Ratings for 10X Genomics (TXG)
TXG Rating Summary
TXG Price Target Summary
- Highest: $70.00 (RBC Capital)
- Lowest: $17.00 (Jefferies)
- Average: $41.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$41.00 (-39.1%)
* Over Last 12-Mos
Rating Score: 3.5 / 10
Percentile Rank: 33%
Avg. $ Target:
$41.00 (-39.1%)
* Over Last 12-Mos
Rating Score: 3.5 / 10
Percentile Rank: 33%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | UBS | Douglas Schenkel | New Coverage | Neutral (N/A) |
68.00 (N/A) |
65.60 (67.29) |
2.58% | Details |
| 9/1/2026 | RBC Capital | Dan Leonard | New Coverage | Sector Perform (N/A) |
70.00 (N/A) |
61.54 (67.29) |
9.34% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
